Adrian Buckner
Psychiatry · Bristol, TNNPI 1437169901
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,596 of the $64,211 with a category attached, or 77.2%. 20 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 41.7% of the total. Reporting peaked in 2019 at $26,872 and has fallen 81.6% since, to $4,954 in 2022. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 650 payments — averaging $98.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$27K
- AbbVie$14K
- Alkermes, Inc.$10K
- Teva Pharmaceuticals USA, Inc.$5K
- Johnson & Johnson$4K
- Sunovion Pharmaceuticals Inc.$1K
- plus $3K from 14 others
What the payments were for
- Consulting fees$8881%
- Speaking & faculty fees$49,59677%
- Travel & lodging$3,8246%
- Food & beverage$9,63215%
- Education$2720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 113 | $26,754 |
| AbbVie(2 entities) | 98 | $14,439 |
| Alkermes, Inc. | 51 | $9,698 |
| Teva Pharmaceuticals USA, Inc. | 60 | $4,880 |
| Johnson & Johnson | 52 | $4,000 |
| Sunovion Pharmaceuticals Inc. | 93 | $1,177 |
| Lundbeck LLC | 59 | $902 |
| Bausch Health US, LLC | 34 | $605 |
| Neurocrine Biosciences, Inc. | 23 | $511 |
| Vanda Pharmaceuticals Inc. | 22 | $397 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $269 |
| Ironshore Pharmaceuticals Inc. | 6 | $143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $135 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $88 |
| Eisai Inc. | 4 | $74 |
| Avanir Pharmaceuticals, Inc. | 4 | $71 |
| Almatica Pharma LLC | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Neuronetics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$31,646
- ABILIFY MAINTENA$24,861
- VRAYLAR$13,361
- AUSTEDO$3,780
- ARISTADA$3,552
- SPRAVATO$3,300
- REXULTI$1,100
- ARISTADA INITIO$888
- LATUDA$109
How this compares
$64,211 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.
Other psychiatry in Bristol
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- John FenleyJohnson City$1.4M
- David SnowMaryville$605K
- Karthi NamasivayamKnoxville$225K
- Robert JamiesonNashville$141K
- George BrownJohnson City$91K
- Sricharan MoturiFranklin$82K
- Michelle CochranNashville$74K
- Daniel BoydMemphis$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.